We used a PCR method to quantify the loads of Chlamydia trachomatis organisms in self-collected urine and vulvovaginal swab (VVS) samples from 93 women and 30 men participating in the Chlamydia Screening Studies Project, a community-based study of individuals not seeking health care. For women, self-collected VVS had a higher mean chlamydial load (10,405 organisms/ml; 95% confidence interval [95% CI], 5,167 to 21,163 organisms/ml) than did first-void urines (FVU) (503 organisms/ml; 95% CI, 250 to 1,022 organisms/ml; P < 0.001). Chlamydial loads in female and male self-collected FVU specimens were similar (P ؍ 0.634). The mean chlamydial load in FVU specimens decreased with increasing age in females and males. There was no strong statistical evidence of differences in chlamydial load in repeat male and female FVU specimens taken when patients attended for treatment a median of 23.5 (range, 14 to 62) and 28 (range, 13 to 132) days later, respectively, or in VVS taken a median of 35 (range, 14 to 217) days later. In this study, chlamydial load values for infected persons in the community who were not seeking treatment were lower than those published in other studies involving symptomatic patients attending clinical settings. This might have implications for estimates of the infectiousness of chlamydia. The results of this study provide a scientific rationale for preferring VVS to FVU specimens from women.Nucleic acid amplification tests to detect Chlamydia trachomatis have revolutionized the diagnosis and management of this common treatable sexually transmitted infection (6). Increased test sensitivity has enabled the use of noninvasive specimens, such as first-void urine specimens for men and women and vulvovaginal swabs for women, thus dispensing with the need for a genital examination and making it easier to perform screening tests on people without symptoms suggestive of chlamydial infection.The burden of C. trachomatis organisms in the genital tract (chlamydial load) can vary from 10 to over a million organisms per milliliter of genital tract secretions (4,8). This is likely to influence the performance of different nucleic acid amplification tests, which do not routinely distinguish between people with high and low chlamydial loads (4, 8). Differences in chlamydial load have been reported to be associated with the presence of clinical symptoms (2, 8), the transmissibility and persistence of infection (3, 10), and the risk of developing chronic sequelae (2). Studies investigating the relevance of chlamydial load so far have been conducted only with patients attending health care settings (2,4,8). The objectives of this study were to measure chlamydial loads in individuals in a community setting and to investigate factors associated with chlamydial load.
MATERIALS AND METHODSWe used specimens from people participating in the Chlamydia Screening Studies (ClaSS) project, which has been described in detail elsewhere (5, 7, 11). In brief, specimens were collected at home from February 2000 to August 2001 by women...